Standing Commission on Vaccinations (Stiko) until it recommends vaccination with anti-coronavirus vaccines from two different manufacturers to speed up the vaccination process.
This was stated in Geneva by the official representative of the WHO, Margaret Harris. The available data are insufficient to say whether a combination of different drugs against COVID-19 is possible, she said.
Harris recalled that the Strategic Advisory Group of Experts (SAGE) on Immunization advised the use of the same product for both doses, while advising the Swedish-British company AstraZeneca, which the Robert Koch Institute’s Standing Commission on Vaccinations (Stiko) at Berlin considers it safe.
Earlier, the European Medicines Agency (EMA) added information about the possibility of thrombosis to the description of the AstroZeneca vaccine, now called Vaxzevria. “The combination of thrombosis and thrombocytopenia, sometimes accompanied by bleeding, is very rare after vaccination with Vaxzevria,” says the description of the vaccine.
WHO spokesman Margaret Harris advises using the same product for both doses of the vaccine.
Germany says this:
Face-to-face classes in schools are again suspended – the opening date is not named
The plans of the office became known – quarantine for 6 – 8 weeks
Keeping savings costs money – 300 banks charge negative interest